Story perspectives
DEA Places Kratom Compounds MGM-15, MGM-16 in Schedule I
9/1/2026
1 of 1
Story summary
- The U.S. Department of Justice, through the DEA, placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I on August 25.
- Attorney General Todd Blanche said the scheduling protects children and communities from drug addiction and abuse.
- Massachusetts health commissioner Michael Goldstein issued an emergency regulation on August 28 banning all kratom due to overdose risks.
- Retailers sued, arguing the ban exceeds authority because traditional kratom leaf remains unscheduled federally.
